Review of laboratory findings for patients with chronic fatigue syndrome

Reviews of Infectious Diseases

Volumn 13, Issue , 1991, Pages S12-S18

  Buchwald, Dedra ^a   Komaroff, Anthony L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COMPLEMENT; CYTOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ALLERGY; ANTIBODY BLOOD LEVEL; ANTIGEN ANTIBODY COMPLEX; B LYMPHOCYTE; CHEMISTRY; CHRONIC FATIGUE SYNDROME; CONFERENCE PAPER; EPSTEIN BARR VIRUS; HEMATOLOGY; HUMAN; IMMUNOGLOBULIN PRODUCTION; LABORATORY DIAGNOSIS; MONOCYTE; MUSCLE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

AUTOANTIBODIES; B-LYMPHOCYTES; FATIGUE SYNDROME, CHRONIC; HUMAN; IMMUNOGLOBULINS; KILLER CELLS, NATURAL; MUSCLES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; VIRUSES;

EID: 0025834465     PISSN: 01620886     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/13.Supplement_1.S12     Document Type: Article

References (61)

1. Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE, Jones JF, Dubois RE, Cunningham-Rundles C, Pahwa S, Tosato G, Zegans LS, Purtillo DT, Brown N, Schooley RT, Brus I. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988;108:387-9.
2. Aoki T, Usuda Y, Miyakoshi H, Tamura K, Herberman RB. Low natural killer syndrome: clinical and immunologic features. Nat Immun Cell Growth Regul 1987;6:116-28
3. Kaslow JE, Rucker L, Onishi R. Liver extract-folic acid-cyanocobala- min vs. placebo for chronic fatigue syndrome. Arch Intern Med 1989;149:2501-3
4. Lloyd AR, Wakefield D, Boughton CR, Dwyer JM. Immunological abnormalities in the chronic fatigue syndrome. Med J Aust 1989;151: 122-4
5. Behan PO, Behan WHM, Bell EJ. The postviral fatigue syndrome-an analysis of the findings in 50 cases. J Infect 1985;10:211-22
6. Borysiewicz LK, Haworth SJ, Cohen J, Mundin J, Rickinson A, Sissons JGP. Epstein-Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis. Q J Med 1986; 58:111-21
7. DuBois RE, Seeley JK, Brus I, Sakamoto K, Ballow M, Harada S, Bechtold TA, Pearson G, Purtilo DT. Chronic mononucleosis syndrome. South Med J 1984;77:1376-82
8. Salit IE. Sporadic postinfectious neuromyasthenia. Can Med Assoc J 1985;133:659-63
9. Tobi M, Morag A, Ravid Z, Chowers I, Feldman-Weiss V, Michaeli Y, Ben-Chetrit E, Shalit M, Knobler H. Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet 1982;1:61-4
10. Hamblin TJ, Hussain J, Akbar AN, Tang YC, Smith JL, Jones DB. Immunological reason for chronic ill health after infectious mononucleosis. BMJ 1983;287:85-8
11. Jones JF, Ray CG, Minnich LL, Hicks MJ, Kibler R, Locas DO. Evidence of active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med 1985;102:1-7
12. Gold D, Bowden R, Sixbey J, Riggs R, Katon WJ, Ashley R, Obrigewiteh R, Corey L. Chronic fatigue. A prospective clinical and virologic study. JAMA 1990;264:48-53
13. Straus SE, Tosato G, Armstrong G, Lawley T, Preble OT, Henle W, Davey R, Pearson G, Epstein J, Brus I, Blaese RM. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med 1985;102:7-16
14. Kroenke K, Wood DR, Mangelsdorff AD, Meier NJ, Powell JB. Chronic fatigue in primary care: prevalence, patient characteristics, and outcome. JAMA 1988;260:929-34
15. Roubalová K, Roubal J, Skopový P, Fučíková T, Domorázková E, Vonka V. Antibody response to Epstein-Barr virus antigens in patients with chronic viral infection. J Med Virol 1988;25:115-22
16. Lane TJ, Manu P, Matthews DA. Prospective diagnostic evaluation of adults with chronic fatigue. Clin Res 1988;36:714A
17. Prieto J, Subira ML, Castilla A, Serrano M. Naloxone-reversible monocyte dysfunction in patients with chronic fatigue syndrome. Scand J Immunol 1989;30:13-20
18. Weinstein L. Thyroiditis and “chronic infectious mononucleosis” [letter], N Engl J Med 1987;317:1225-6
19. Read R, Spickett G, Harvey J, Edwards AJ, Larson HE. IgGl subclass deficiency in patients with chronic fatigue syndrome [letter]. Lancet 1988;1:241-2
20. Tosato G, Straus S, Henle W, Pike SE, Blaese RM. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). J Immunol 1985;134: 3082-8
21. Komaroff AL, Geiger AM, Wormsely. IgG subclass deficiencies in chronic fatigue syndrome [letter]. Lancet 1988;1:1288-9
22. Linde A, Hammarstrom L, Smith CIE. IgG subclass deficiency and chronic fatigue syndrome [letter]. Lancet 1988;1:885-6
23. Morag A, Tobi M, Ravid Z, Revel M, Schattner A. Increased (2'-5')- oligo-a synthetase activity in patients with prolonged illness associated with serological evidence of persistent Epstein-Barr virus infection [letter]. Lancet 1982;1:744
24. Ho-Yen DO, Carrington D, Armstrong AA. Myalgic encephalomyelitis and alpha-interferon [letter]. Lancet 1988;1:125
25. Lloyd A, Hanna DA, Wakefield D. Interferon and myalgic encephalomyelitis [letter]. Lancet 1988;1:471
26. Altmann C, Larratt K, Golubjatnikov R, Kirmani N, Rytel M. Immunologic markers in the chronic fatigue syndrome [abstract], Clin Res 1988;36:845A
27. Kibler R, Lucas DO, Hicks MJ, Poulos BT, Jones JF. Immune function in chronic active Epstein-Barr virus infection. J Clin Immunol 1985;5:46-54
28. Morte S, Castilla A, Civeira M-P, Serrano M, Prieto J. Gamma-interferon and chronic fatigue syndrome [letter]. Lancet 1988;2:623-4
29. Cheney PR, Dorman SE, Bell DS. Interleukin-2 and the chronic fatigue syndrome. Ann Intern Med 1989;110:321
30. Murdoch JC. Cell-mediated immunity in patients with myalgic encephalomyelitis syndrome. N Z Med J 1988;101:511-2
31. Dubois RE. Gamma globulin therapy for chronic mononucleosis syndrome. AIDS Res 1986;2(Suppl l):S191-5
32. Subirá ML, Castilla A, Civeira MP, Prieto J. Deficient display of CD3 on lymphocytes of patients with chronic fatigue syndrome. J Infect Dis 1989;160:165-6
33. Caligiuri M, Murray C, Buchwald D, Levine H, Cheney P, Peterson D, Komaroff AL, Ritz J. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol 1987;139:3306-13
34. Hellinger WC, Smith TF, Van Scoy RE, Spitzer PG, Forgacs P, Edson RS. Chronic fatigue syndrome and the diagnostic utility of antibody to Epstein-Barr virus early antigen. JAMA 1988;260:971-3
35. Horwitz CA, Henle W, Henle G, Rudnick H, Latts E. Long-term serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis. J Infect Dis 1985;151:1150-3
36. Lamy ME, Favart AM, Cornu C, Mendez M, Segas M, Burtonboy G. Study of Epstein Barr virus (EBV) antibodies: IgG and IgM anti-VCA, IgG anti-EA and Ig anti-EBNA obtained with an original microtiter technique; serological criterions of primary and recurrent EBV infections and follow-up of infectious mononucleosis; seroepidemiology of EBV in Belgium based on 5178 sera from patients. Acta Clin Belg 1982;37:281-98
37. Buchwald D, Sullivan JL, Komaroff AL. Frequency of ‘chronic active Epstein-Barr virus infection’ in a general medical practice. JAMA 1987;257:2303-7
38. Holmes GP, Kaplan JE, Stewart JA, Hunt B, Pinsky PF, Schonberger LB. A cluster of patients with a chronic mononucleosis-like syndrome: is Epstein-Barr virus the cause? JAMA 1987;257:2297-302
39. Hotchin NA, Read R, Smith DG, Crawford DH. Active Epstein-Barr virus infection in post-viral fatigue syndrome. J Infect 1989;18:143-50
40. Waters-Peacocke N, Wray BB, Ades EW. A prospective study: evaluation of the antibody-dependent cell-mediated cytotoxicity assay in chronic active Epstein-Barr syndrome. J Clin Lab Immunol 1988; 27:11-2
41. Henle W, Henle G, Andersson J, Embetg I, Klein G, Horwitz CA, Marklund G, Rymo L, Wellinder C, Straus SE. Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proc Natl Acad Sci USA 1987;84:570-4
42. Miller G, Grogan E, Fischer DK, Niederman JC, Schooley RT, Henle W, Lenoir G, Liu C-R. Antibody responses to two Epstein-Barr virus nuclear antigens defined by gene transfer. N Engl J Med 1985; 312:750-5
43. Miller G, Grogan E, Rowe D, Rooney C, Heston L, Eastman R, Andiman W, Niederman J, Lenoir G, Henle W, Sullivan J, Schooley R, Vossen J, Strauss S, Issekutz T. Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein- Barr virus infection. J Infect Dis 1987;156:26-35
44. Jones JF, Williams M, Schooley RT, Robinson C, Glaser R. Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome. Arch Intern Med 1988;148:1957-60
45. Linde A, Andersson J, Lundgren G, Wahren B. Subclass reactivity to Epstein-barr virus capsid antigen in primary and reactivated EBV infections. J Med Virol 1987;21:109-21
46. Halpin D, Wessely S. VP-1 antigen in chronic postviral fatigue syndrome [letter]. Lancet 1989;1:1028-9
47. Yousef GE, Bell EJ, Mann GF, Murugesan V, Smith DG, McCartney RA, Mowbray JF. Chronic enterovirus infection in patients with postviral fatigue syndrome. Lancet 1988;1:146-50
48. Archard LC, Bowles NE, Behan PO, Bell EJ, Doyle D. Postviral fatigue syndrome: persistence of enterovirus RNA in muscle and elevated creatine kinase. J R Soc Med 1988;81:326-9
49. Komaroff AL, Saxinger C, Buchwald D, Geiger A, Gallo RC. A chronic “post-viral” fatigue syndrome with neurologic features: serologic association with human herpesvirus-6 (HHV-6). Clin Res 1988;36:743A
50. Wakefield D, Lloyd A, Dwyer J, Salahuddin SZ, Ablashi DV. Human herpesvirus 6 and myalgic encephalomyelitis [letter]. Lancet 1988; 1:1059
51. Jones JF, Straus SE. Chronic Epstein-Barr virus infection. Annu Rev Med 1987;38:195-209
52. Straus SE, Dale JK, Wright R, Metcalfe DD. Allergy and the chronic fatigue syndrome. J Allergy Clin Immunol 1988;81:791-5
53. Olson GB, Kanaan MN, Gersuk GM, Kelley LM, Jones JF. Correlation between allergy and persistent Epstein-Barr virus infections in chronic-active Epstein-Barr virus infected patients. J Allergy Clin Immunol 1986;78:308-14
54. Olson GB, Kanaan MN, Kelley LM, Jones JF. Specific allergen-induced Epstein-Barr nuclear antigen-positive B cells from patients with chronic-active Epstein-Barr virus infections. J Allergy Clin Immunol 1986;78:315-20
55. Jamal GA, Hansen S. Electrophysiological studies in the post-viral fatigue syndrome. J Neurol Neurosurg Psychiatry 1985;48:691-4
56. Warner CL, Cookfair D, Heffner R, Bell D, Ley D, Jacobs L. Neurologic abnormalities in the chronic fatigue syndrome [abstract]. Neurology 1989;39(Suppl 1):420
57. 31P nuclear magnetic resonance study. Lancet 1984;1:1367-9
58. Byrne E, Trounce I. Chronic fatigue and myalgia syndrome: mitochondrial and glycolytic studies in skeletal muscle. J Neurol Neurosurg Psychiatry 1987;50:743-6
59. Lloyd AR, Hales JP, Gandevia SC. Muscle strength, endurance and recovery in the post-infection fatigue syndrome. J Neurol Neurosurg Psychiatry 1988;51:1316-22
60. Stokes MJ, Cooper RG, Edwards RH. Normal muscle strength and fatigability in patients with effort syndromes. BMJ 1988;297:1014-7
61. Montague TJ, Marrie TJ, Klassen GA, Berwick DJ, Horacek BM. Cardiac function at rest and with exercise in the chronic fatigue syndrome. Chest 1989;95:779-84